- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06562465
Prevention and Intervention of Overweight and Obesity in Preschool Children
Research on Prevention and Intervention of Overweight and Obesity in Preschool Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Procedures. Step 1: Epidemiological survey: Conduct a health survey on preschool children in selected kindergartens to understand the prevalence and risk factors of overweight and obese children; Phase 2: Recruit overweight and obese children from kindergartens with a population of over 200 in Chongqing, and randomly divide them into an intervention group and a blank control group. Dietary and exercise management, combined with reward and support mechanism monitoring, were implemented for the intervention group, while the blank control group did not receive the aforementioned interventions. Measure the height, weight, BMI, questionnaire survey, blood indicators, etc. of the children before and after the intervention, and use them as evaluation indicators.
- The sample size for comparing the means of the two groups is N=(Z α/2+Z β) 2 σ 2 (Q1-1+Q2-1)/δ 2. If the difference in BMI decrease between the two groups after intervention is 0.58, and if σ=1.2 and α is taken as 0.05 on both sides, the test power is 0.8, Q1=Q2=0.5,σ=1.2,δ=0.58,Z0.05/2=1.96,Zβ=0.842, Calculate N=(1.96+0.842) 2 * 1.22 * (0.5-1+0.5-1)/0.582 ≈ 69, taking into account the situation of loss to follow-up and refusal to follow up at 20%. The final required two groups of research subjects are 87, and a total of at least 174 research subjects will be included.
4. Statistical analysis. SPSS 26.0 software was used for statistical analysis, and descriptive statistics were performed on general demographic data. Count data was expressed as n (%), and inter group comparisons of rates were performed using a 2-test. Continuous variables that followed a normal distribution were described as mean ± standard deviation (x ± s), and inter group comparisons were performed using t-test. All tests were two-sided, and the test level α was set to 0.05. Multivariate logistic regression analysis of the correlation between nutritional status and risk factors. Using rank sum test to compare the differences in various indicators before and after intervention in obese and overweight children.
5.Ethical matters and data protection. The patients participated in the study will sign the informed consent (obtained from the guardian). And this study was approved by the local ethics committee. Patient's name will be abbreviated and the research data will be assigned a code then to provide to the researcher. The authorization from parents on the patient's health information remains valid until the study is completed. After that, researchers will delete private information from the study record.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Chongqing, China
- Recruiting
- Children's Hospital of Chongqing Medical University
-
Contact:
- Li Chen
- Phone Number: 86 136 7762 0103
- Email: chenli2012@126.com
-
Contact:
- Jinwei Tu
- Phone Number: 86 17830831834
- Email: 1522753518@qq.com
-
-
Chongqing
-
Chongqing, Chongqing, China, 400014
- Recruiting
- Growth,Development and Mental Health of Children and Adolescents Center
-
Contact:
- Li Chen, MD
- Phone Number: +86 (+86)13677620103
- Email: chenli2012@126.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
overweight or obese Children Currently, there are no projects related to overweight and obesity management (such as weight loss management, etc.) Parents and children are willing to accept dietary and exercise management for a period of 4 months Willing to measure height, weight, BMI, blood pressure, body composition, questionnaire survey (exercise, diet, etc.) and other items before intervention and 1 month, 2 months, 3 months, and 4 months after intervention (a total of 5 times) Willing to undergo blood tests before and 4 months after intervention (2 times in total); The questionnaire information is filled in accurately and meets the questionnaire quality control standards
Exclusion Criteria:
Recruiter exclusion criteria:
Preschool children with underlying diseases (such as congenital heart disease, liver and kidney disease, thyroid disease, malignant tumors, etc.) or uncontrolled underlying diseases
Questionnaire exclusion criteria:
Incorrect information filling in the questionnaire, which does not meet the questionnaire quality control standards
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
The overweight and obese children aged 3-6 years old,receive dietary and exercise management, combined reward support mechanisms.
|
Dietary and exercise management: dietary management by providing tailored recipes, health education lectures, science competitions, etc;exercise management:develop weekly and monthly exercise plans for children of different ages, and have physical education teachers lead them in exercising.
|
|
Active Comparator: Control group
The overweight and obese children aged 3-6 years old only receive basic health guidance,do not receive dietary and exercise management nor combined reward support mechanisms like experimental group.
|
NO dietary and exercise management:do not implement dietary and exercise management related to the experimental group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI
Time Frame: 3-4 months
|
Changes in BMI between the experimental group and intervention group at the beginning and end of the project
|
3-4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition--Fat (%)
Time Frame: 3-4 months
|
Changes in Body composition including Fat (%) between the experimental group and intervention group at the beginning and end of the project.
|
3-4 months
|
|
Body composition--Body fat index (BFMI)
Time Frame: 3-4 months
|
Changes in Body composition including Body fat index (BFMI) between the experimental group and intervention group at the beginning and end of the project.
|
3-4 months
|
|
Body composition--Fat-free mass index (FFMI)
Time Frame: 3-4 months
|
Changes in Body composition including Fat-free mass index (FFMI) between the experimental group and intervention group at the beginning and end of the project.
|
3-4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
questionnaire investigation
Time Frame: 3-4 months
|
Changes in questionnaire investigation(involving diet, exercise, and obesity awareness) between the experimental group and intervention group at the beginning and end of the project
|
3-4 months
|
|
Blood indicators--ALT
Time Frame: 3-4 months
|
Changes in blood indicators including glutamic-pyruvic transaminase (ALT) between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--AST
Time Frame: 3-4 months
|
Changes in blood indicators including glutamic-oxaloacetic transaminase(AST) between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--creatinine
Time Frame: 3-4 months
|
Changes in blood indicators including creatinine between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--uric acid
Time Frame: 3-4 months
|
Changes in blood indicators including uric acid between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--urea
Time Frame: 3-4 months
|
Changes in blood indicators including urea between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--blood sugar
Time Frame: 3-4 months
|
Changes in blood indicators including blood sugar between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--triglyceride
Time Frame: 3-4 months
|
Changes in blood indicators including triglyceride between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--cholesterol
Time Frame: 3-4 months
|
Changes in blood indicators including cholesterol between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--high-density
Time Frame: 3-4 months
|
Changes in blood indicators including high-density lipoprotein between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--low density lipoprotein
Time Frame: 3-4 months
|
Changes in blood indicators including low density lipoprotein between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--VD
Time Frame: 3-4 months
|
Changes in blood indicators including VD between the experimental group and intervention group at the beginning and end of the of the project.
|
3-4 months
|
|
Blood indicators--VA
Time Frame: 3-4 months
|
cators including VA between the experimental group and intervention group
|
3-4 months
|
|
Blood indicators--ferritin
Time Frame: 3-4 months
|
cators including ferritin between the experimental group and intervention group
|
3-4 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Dong YH, Chen L, Liu JY, Ma T, Zhang Y, Chen MM, Zhong PL, Shi D, Hu PJ, Li J, Dong B, Song Y, Ma J. [Epidemiology and prediction of overweight and obesity among children and adolescents aged 7-18 years in China from 1985 to 2019]. Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Feb 28;57:11-19. doi: 10.3760/cma.j.cn112150-20220906-00881. Online ahead of print. Chinese.
- Lister NB, Baur LA, Felix JF, Hill AJ, Marcus C, Reinehr T, Summerbell C, Wabitsch M. Child and adolescent obesity. Nat Rev Dis Primers. 2023 May 18;9(1):24. doi: 10.1038/s41572-023-00435-4.
- Hughes AR, Sherriff A, Ness AR, Reilly JJ. Timing of adiposity rebound and adiposity in adolescence. Pediatrics. 2014 Nov;134(5):e1354-61. doi: 10.1542/peds.2014-1908. Epub 2014 Oct 13.
- Brown T, Moore TH, Hooper L, Gao Y, Zayegh A, Ijaz S, Elwenspoek M, Foxen SC, Magee L, O'Malley C, Waters E, Summerbell CD. Interventions for preventing obesity in children. Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD001871. doi: 10.1002/14651858.CD001871.pub4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OABIPC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Massachusetts General HospitalDenver Health and Hospital Authority; Prisma Health-UpstateCompletedOverweight and Obesity | Severe ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
Clinical Trials on dietary and exercise management
-
Korea University Anam HospitalThe Korean Vascular Research Working GroupCompleted
-
Technical University of LisbonCompleted
-
National Institute on Aging (NIA)Completed
-
Universidad Francisco de VitoriaCompleted
-
Hamilton Health Sciences CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteAmerican Cancer Society, Inc.Completed
-
Peking Union Medical College HospitalUnknownChronic Disease | Dietary FiberChina
-
Changhua Christian HospitalNational Taipei University of Nursing and Health Sciences; Taipei Veterans...Active, not recruitingLung Neoplasm Malignant | Cachexia-Anorexia SyndromeTaiwan
-
Washington State, Department of HealthUniversity of Washington; NorthWest Orthopaedic Institute; Spokane Regional Health... and other collaboratorsCompleted
-
Hospices Civils de LyonRecruitingCirrhosis | Undernutrition | Fragility | Hepatic TransplantationFrance